Facilities are not in state of good repair.
Inspection Record
Kamada Ltd. — FDA 483 Findings
Inspectors Pete Amin · Olga SimakovaThe inspectors who signed the published document.Inspector lookup
View the regulator's official source The source document is always the basis for judgement.
Findings
Adequate process validation for (b) (4) used during the (b) (4) =E step was not for(b) (4) Jr resulted in mishandling of (b) (
During observation of aseptic filling setup procedure, the followings were noted in filling suite"(room(b) ( a.
Internal SOPs, recommendations of the equipment's manufacturer and process control procedures in execution of various production and process control functions are not followed, and non -validated "amended" procedures are used when equipment and processes fail.
Failure to establish adequate written procedures for the labelling of the (b) (4) drug substance) to assure the proper labelling and to prevent mix ups of the drug substance stored in multi -product facility.
A record as of the US FDA document published on 2026-10-20. Check the agency's announcements for any later corrective action, and rely on the original text. Translation and classification are machine-made.